3.0
Jun 4, 2014
Recommend
CEO approval
Business Outlook
Pros
Strong pipeline, shedding old Abbott ways, opportunities to develop new identity, uk business seems to be more empowered to innovate than regional or corporate functions
Cons
Entrenched in bureaucracy, many layers of senior management, strong US focus, old systems, many restrictive procedures, generic bio pharma strategy